June 5th- Beyond the Webinar: Apheresis: The Forgotten Backbone of Cellular Therapy CME Congresses . June 5th- Beyond the Webinar: Apheresis: The Forgotten Backbone of Cellular Therapy June 2nd- LIVE from #ASCO26- Philadelphia-Positive ALL: The End of Chemotherapy and the Beginning of a New Era? CME Congresses . June 2nd- LIVE from #ASCO26- Philadelphia-Positive ALL: The End of Chemotherapy and the Beginning of a New Era? June 1st- LIVE from #ASCO26- frontMIND: The First Real Challenge to R-CHOP in High-Risk DLBCL? CME Congresses . June 1st- LIVE from #ASCO26- frontMIND: The First Real Challenge to R-CHOP in High-Risk DLBCL? May 31st- ASCO 2026: Teclistamab Changes the Rules at First Relapse — The Practice-Changing MajesTEC-9 Trial CME Congresses . May 31st- LIVE from #ASCO26- Teclistamab Changes the Rules at First Relapse — The Practice-Changing MajesTEC-9 Trial May 31st- SUCCESSOR-2: Has Mezigdomide Just Redefined Relapse Therapy in Multiple Myeloma? CME Congresses . May 31st- LIVE from #ASCO26- SUCCESSOR-2: Has Mezigdomide Just Redefined Relapse Therapy in Multiple Myeloma? May 29th- Beyond the Webinar: Can We Finally Modify the Natural History of Myelofibrosis? CME Congresses . May 29th- Beyond the Webinar: Can We Finally Modify the Natural History of Myelofibrosis? May 27th- CAR-T Before It’s Too Late: The New Myeloma Revolution CME Congresses . May 27th- CAR-T Before It’s Too Late: The New Myeloma Revolution May 25th- Dr. Satoshi Yamasaki- GVHD prophylaxis after cord blood transplantation in patients with high-risk AML: a nationwide Japanese cohort study CME Congresses . May 25th- Dr. Satoshi Yamasaki- GVHD prophylaxis after cord blood transplantation in patients with high-risk AML: a nationwide Japanese cohort study May 21st- From Dysbiosis to Therapeutics: The New Era of Microbiota in Allo-HCT CME Congresses . May 21st- From Dysbiosis to Therapeutics: The New Era of Microbiota in Allo-HCT May 18th- Can Peripheral Blood Replace Bone Marrow for MRD Monitoring in Myeloma? CME Congresses . May 18th- Can Peripheral Blood Replace Bone Marrow for MRD Monitoring in Myeloma? Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Page21 Page22 Page23
